Clinical Trial Update: Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anastrozole, letrozole, or exemestane with or without tamoxifen in postmenopausal women with hormone-responsive breast cancer after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)
• Letrozole (letrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Gruppo Italiano Mammella (GIM) | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN